Valsecchi ME - Search Results

1

RB-pathway disruption is associated with improved response to neoadjuvant chemotherapy in breast cancer.

Witkiewicz AK, Ertel A, McFalls J, Valsecchi ME, Schwartz G, Knudsen ES. Witkiewicz AK, et al. Among authors: valsecchi me. Clin Cancer Res. 2012 Sep 15;18(18):5110-22. doi: 10.1158/1078-0432.CCR-12-0903. Epub 2012 Jul 18. Clin Cancer Res. 2012. PMID: 22811582 Free PMC article.

2

Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.

Valsecchi ME, McDonald M, Brody JR, Hyslop T, Freydin B, Yeo CJ, Solomides C, Peiper SC, Witkiewicz AK. Valsecchi ME, et al. Cancer. 2012 Jul 15;118(14):3484-93. doi: 10.1002/cncr.26661. Epub 2011 Nov 15. Cancer. 2012. PMID: 22086503 Free article.

3

Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?

Valsecchi ME, Holdbrook T, Leiby BE, Pequignot E, Littman SJ, Yeo CJ, Brody JR, Witkiewicz AK. Valsecchi ME, et al. BMC Cancer. 2012 Mar 22;12:104. doi: 10.1186/1471-2407-12-104. BMC Cancer. 2012. PMID: 22436573 Free PMC article.

4

Somatostatin receptor scintigraphy in patients with metastatic uveal melanoma.

Valsecchi ME, Coronel M, Intenzo CM, Kim SM, Witkiewicz AK, Sato T. Valsecchi ME, et al. Melanoma Res. 2013 Feb;23(1):33-9. doi: 10.1097/CMR.0b013e32835b70e9. Melanoma Res. 2013. PMID: 23164993

5

Reduced risk of bone metastasis for patients with breast cancer who use COX-2 inhibitors.

Valsecchi ME, Pomerantz SC, Jaslow R, Tester W. Valsecchi ME, et al. Clin Breast Cancer. 2009 Nov;9(4):225-30. doi: 10.3816/CBC.2009.n.038. Clin Breast Cancer. 2009. PMID: 19933077

6

Recent treatment advances and novel therapies in pancreas cancer: a review.

Valsecchi ME, Díaz-Cantón E, de la Vega M, Littman SJ. Valsecchi ME, et al. J Gastrointest Cancer. 2014 Jun;45(2):190-201. doi: 10.1007/s12029-013-9561-z. J Gastrointest Cancer. 2014. PMID: 24343588 Free PMC article. Review.

7

Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis.

Valsecchi ME, Silbermins D, de Rosa N, Wong SL, Lyman GH. Valsecchi ME, et al. J Clin Oncol. 2011 Apr 10;29(11):1479-87. doi: 10.1200/JCO.2010.33.1884. Epub 2011 Mar 7. J Clin Oncol. 2011. PMID: 21383281

8

Modifiable factors that influence colon cancer lymph node sampling and examination.

Valsecchi ME, Leighton J Jr, Tester W. Valsecchi ME, et al. Clin Colorectal Cancer. 2010 Jul;9(3):162-7. doi: 10.3816/CCC.2010.n.022. Clin Colorectal Cancer. 2010. PMID: 20643621

9

The potential role of sunitinib targeting melanomas.

Valsecchi ME, Sato T. Valsecchi ME, et al. Expert Opin Investig Drugs. 2013 Nov;22(11):1473-83. doi: 10.1517/13543784.2013.837449. Epub 2013 Sep 19. Expert Opin Investig Drugs. 2013. PMID: 24050392 Review.

10

Immune Check Point Inhibitors Combination in Melanoma: Worth the Toxicity?

Orloff M, Weight R, Valsecchi ME, Sato T. Orloff M, et al. Among authors: valsecchi me. Rev Recent Clin Trials. 2016;11(2):81-6. doi: 10.2174/1574887111666160330120712. Rev Recent Clin Trials. 2016. PMID: 27028970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters